SEARCH

SEARCH BY CITATION

References

  • 1
    Centersfor Disease Control and Prevention. Guidelines for prevention of transmission of human immunodeficiency virus through transplantation of human tissue and solid organs. MMWR 1994; 43: 117.
  • 2
    Centers for Disease Control and Prevention. Public Health Service guideline for reducing transmission of human immuno deficiency virus(HIV), hepatitis B virus(HBV), and hepatitis C virus (HCV) through solid organ transplantation. Docket CDC-2011-0011. http://federalregister.gov/a/2011-30205. Accessed January 28, 2012.
  • 3
    American Society of Transplant Surgeons, American Society of Transplantation, Association of Organ Procurement Organizations, and North American Transplant Coor-dinators Organization(NATCO). Letter to Howard Koh, MD, MPH, Assistant Secretary for Health, Department of Health and Human Services. August 23, 2011. http://www.asts.org/Tools/Download.aspx?fid=1438. Accessed January 28, 2012.
  • 4
    Shafer TJ, Schkade D, Schkade L, Geier SS, Orlowski JP, Klintmalm G. Zero risk tolerance costslives:loss of transplantable organs due to human immuno deficiency virus nucleic acid testing of potential donors. Prog Transplant 2011; 21: 236247.
  • 5
    One Legacy. Position Statment on Proposed CDC High Risk Organ Donor Guidelines. December 21, 2011.

References